Compare FOLD & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | OSIS |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 2006 | 1997 |
| Metric | FOLD | OSIS |
|---|---|---|
| Price | $14.46 | $297.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $27.25 | ★ $294.40 |
| AVG Volume (30 Days) | ★ 2.6M | 248.8K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | 18.02 |
| EPS | N/A | ★ 3.39 |
| Revenue | N/A | ★ $1,089,286,000.00 |
| Revenue This Year | $20.50 | $9.86 |
| Revenue Next Year | $18.59 | $5.53 |
| P/E Ratio | ★ N/A | $87.62 |
| Revenue Growth | N/A | ★ 13.35 |
| 52 Week Low | $5.66 | $185.44 |
| 52 Week High | $14.48 | $306.12 |
| Indicator | FOLD | OSIS |
|---|---|---|
| Relative Strength Index (RSI) | 66.60 | 62.47 |
| Support Level | $14.21 | $257.99 |
| Resistance Level | N/A | $306.12 |
| Average True Range (ATR) | 0.02 | 9.28 |
| MACD | -0.01 | 2.97 |
| Stochastic Oscillator | 75.00 | 93.03 |
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.